Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)

Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine. ,vol. 342, pp. 145- 153 ,(2000) , 10.1056/NEJM200001203420301

Erwin K. Kastrup, James R. Boyd, Sally Gifford, Drug facts and comparisons Facts and Comparisons Division, J.B. Lippincott. ,(1977)

Rekha Garg, Salim Yusuf, WD Bussmann, Peter Sleight, Andrew Uprichard, Barry Massie, Barry McGrath, Berit Nilsson, Bertram Pitt, Bruno Magnani, Carol Maskin, Ettore Ambrosioni, Ewa Rucinska, Franz X Kleber, Gary Jennings, Gianni Tognoni, Helmut Drexler, John GF Cleland, Joseph A Franciosa, Jouko Remes, Karl Swedberg, Kenneth Dickstein, Lothar Maass, Marc Pfeffer, Mark A Creager, Maryann Gordon, Michael Joy, Norman Sharpe, Pierre Desche, Robin McGarry, Rory Collins, Steven G Chrysant, Vincenzo Cicchetti, Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 1450- 1456 ,(1995) , 10.1001/JAMA.1995.03520420066040

Paul A Heidenreich, Tina T Lee, Barry M Massie, Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. Journal of the American College of Cardiology. ,vol. 30, pp. 27- 34 ,(1997) , 10.1016/S0735-1097(97)00104-6

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack The Lancet. ,vol. 358, pp. 1033- 1041 ,(2001) , 10.1016/S0140-6736(01)06178-5

H. Mitchell Neurath, Anne I. Goldman, Mary Ann Lavin, Harold W. Schnaper, Annette E. Fitz, Edward D. Frohlich, Bernard Steele, Harold G. Richman, EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA-NHLBI FEASIBILITY TRIAL. Plan and Preliminary Results of a Two-Year Feasibility Trial for a Multicenter Intervention Study to Evaluate the Benefits versus the Disadvantages of Treating Mild Hypertension: Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension? Annals of the New York Academy of Sciences. ,vol. 304, pp. 267- 287 ,(1978) , 10.1111/J.1749-6632.1978.TB25604.X

Bruce M Psaty, Nicholas L Smith, David S Siscovick, Thomas D Koepsell, Noel S Weiss, Susan R Heckbert, Rozenn N Lemaitre, Edward H Wagner, Curt D Furberg, None, Health Outcomes Associated With Antihypertensive Therapies Used as First-Line AgentsA Systematic Review and Meta-analysis JAMA: The Journal of the American Medical Association. ,vol. 277, pp. 739- 745 ,(1997) , 10.1001/JAMA.1997.03540330061036

Jesse A. Berlin, Nan M. Laird, Henry S. Sacks, Thomas C. Chalmers, A comparison of statistical methods for combining event rates from clinical trials Statistics in Medicine. ,vol. 8, pp. 141- 151 ,(1989) , 10.1002/SIM.4780080202

Lars Wilhelmsen, G??ran Berglund, Dag Elmfeldt, Timothy Fitzsimons, Heinz Holzgreve, James Hosie, Per-Erik H??rnkvist, Kjell Pennert, Jaakko Tuomilehto, Hans Wedel, Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. Journal of Hypertension. ,vol. 5, pp. 561- 572 ,(1987) , 10.1097/00004872-198710000-00009